An obese NIDDM patient present with FBS=180 mg% and PPBS=260 mg% Management include-
## **Core Concept**
The management of an obese patient with non-insulin-dependent diabetes mellitus (NIDDM), also known as type 2 diabetes mellitus, involves lifestyle modifications and pharmacological interventions. The patient's blood glucose levels, indicated by fasting blood sugar (FBS) of 180 mg% and post-prandial blood sugar (PPBS) of 260 mg%, are above the normal range, necessitating intervention. The primary goals are to achieve good glycemic control, manage obesity, and prevent complications.
## **Why the Correct Answer is Right**
The correct approach for managing this patient includes lifestyle modifications such as diet and exercise, which are crucial for obesity management and improving insulin sensitivity. Pharmacological treatment options may include metformin as a first-line agent for type 2 diabetes, especially in obese patients, due to its favorable effect on weight and low risk of hypoglycemia. Other options might include sulfonylureas, thiazolidinediones, DPP-4 inhibitors, SGLT2 inhibitors, or GLP-1 receptor agonists, depending on the patient's specific needs and comorbidities.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is not provided, but typically, incorrect options might include therapies not indicated for initial management of type 2 diabetes in an obese patient, such as insulin as the first-line treatment (unless there's a specific indication like diabetic ketoacidosis or severe hyperglycemic hyperosmolar state).
- **Option B:** Similarly, this option is not specified, but it could represent a treatment not suitable for this patient population, such as certain medications that could exacerbate obesity or have adverse effects in patients with specific comorbidities.
- **Option C:** Without specifics, it's hard to judge, but it might represent an incomplete approach, such as only focusing on pharmacotherapy without addressing lifestyle modifications.
- **Option D:** This could potentially represent an incorrect or less appropriate choice for initial management, such as a medication typically used for type 1 diabetes or a condition not directly related to the patient's presentation.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that for obese patients with type 2 diabetes, **metformin** is often considered a first-line pharmacological agent due to its benefits on weight and cardiovascular outcomes. Additionally, **lifestyle modifications**, including dietary changes and increased physical activity, are foundational in the management of type 2 diabetes and obesity.
## **Correct Answer:** .